Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon alpha-2b. Preliminary Results.

MLA

Gugliotta, Luigi, et al. “Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon Alpha-2b. Preliminary Results.” Blood, vol. 106, no. 11, Nov. 2005, p. 4962. EBSCOhost, https://doi.org/10.1182/blood.V106.11.4962.4962.

APA

Gugliotta, L., Bulgarelli, S., Asioli, S., Tieghi, A., Gardini, G., Sabattini, E., Franco, V., Boveri, E., Kvasnicka, H. M., Vianelli, N., Candoni, A., Latagliata, R., Passamonti, F., Rupoli, S., Martinelli, V., Zaccaria, A., Lauria, F., De Biasi, E., Sacchi, S., … Thiele, J. (2005). Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon alpha-2b. Preliminary Results. Blood, 106(11), 4962. https://doi.org/10.1182/blood.V106.11.4962.4962

Chicago

Gugliotta, Luigi, S. Bulgarelli, S. Asioli, A. Tieghi, G. Gardini, E. Sabattini, V. Franco, et al. 2005. “Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon Alpha-2b. Preliminary Results.” Blood 106 (11): 4962. doi:10.1182/blood.V106.11.4962.4962.